Thermo Fisher Scientific Inc. (TMO) Net Profit Margin: 15.18%
Is Thermo Fisher Scientific Inc.’s net profit margin high or low?
Thermo Fisher Scientific Inc.'s net profit margin of 15.18% is in line with its 5-year average of 16.47%, near the low end of its 5-year range (13.99%–19.79%).
As of Sunday, June 14, 2026. 1.57% above its 12-month average of 14.95%.
TMO Net Profit Margin Chart
TMO Average Net Profit Margin Chart
TMO Current vs Average Net Profit Margin Chart
TMO Net Profit Margin Metrics
NET PROFIT MARGIN
15.18%
NET PROFIT MARGIN AVG TTM
14.95%
NET PROFIT MARGIN AVG 3Y
14.84%
NET PROFIT MARGIN AVG 5Y
16.47%
NET PROFIT MARGIN AVG 10Y
14.43%
NET PROFIT MARGIN AVG 15Y
13.13%
NET PROFIT MARGIN AVG 20Y
11.84%
CURRENT VS TTM AVG
+1.57%
CURRENT VS 3Y AVG
+2.31%
CURRENT VS 5Y AVG
-7.85%
CURRENT VS 10Y AVG
+5.21%
CURRENT VS 15Y AVG
+15.65%
CURRENT VS 20Y AVG
+28.20%
TMO Competitors' Net Profit Margin
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc. (TMO) | $174.42B | 15.18% | 14.95% | 14.84% | 16.47% |
| Amgen Inc. (AMGN) | $191.70B | 20.95% | 16.61% | 20.49% | 22.20% |
| Gilead Sciences, Inc. (GILD) | $155.93B | 30.99% | 15.29% | 17.07% | 15.27% |
| Abbott Laboratories (ABT) | $153.59B | 13.91% | 23.34% | 19.20% | 17.71% |
| Pfizer Inc. (PFE) | $149.38B | 11.83% | 12.51% | 14.97% | 18.18% |
| Intuitive Surgical, Inc. (ISRG) | $145.58B | 28.15% | 28.09% | 25.67% | 26.14% |
| CVS Health Corporation (CVS) | $130.09B | 0.72% | 0.84% | 1.34% | 1.79% |
| Danaher Corporation (DHR) | $127.47B | 14.89% | 15.52% | 19.51% | 19.37% |
| Bristol-Myers Squibb Company (BMY) | $116.66B | 15.01% | -1.95% | 6.91% | 3.59% |
| Vertex Pharmaceuticals Incorporated (VRTX) | $112.92B | 35.40% | 13.94% | 25.44% | 29.40% |
Margin Comparison
Operating Margin
17.8%
Net Profit Margin
15.2%
Thermo Fisher Scientific Inc. Net Profit Margin Formula & Definition
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Thermo Fisher Scientific Inc. Net Profit Margin FAQ
- What is the net profit margin for Thermo Fisher Scientific Inc. (TMO)?
- The net profit margin for TMO stock is 15.18%.
- Is Thermo Fisher Scientific Inc.'s net profit margin high or low?
- Thermo Fisher Scientific Inc.'s net profit margin of 15.18% is in line with its 5-year average of 16.47%, near the low end of its 5-year range (13.99%–19.79%).
- What is the TTM average net profit margin for Thermo Fisher Scientific Inc. (TMO)?
- The TTM average net profit margin for TMO stock is 14.95%.
- What is the 3Y average net profit margin for Thermo Fisher Scientific Inc. (TMO)?
- The 3Y average net profit margin for TMO stock is 14.84%.
- What is the 5Y average net profit margin for Thermo Fisher Scientific Inc. (TMO)?
- The 5Y average net profit margin for TMO stock is 16.47%.
- What is the 10Y average net profit margin for Thermo Fisher Scientific Inc. (TMO)?
- The 10Y average net profit margin for TMO stock is 14.43%.
- What is the 15Y average net profit margin for Thermo Fisher Scientific Inc. (TMO)?
- The 15Y average net profit margin for TMO stock is 13.13%.
- What is the 20Y average net profit margin for Thermo Fisher Scientific Inc. (TMO)?
- The 20Y average net profit margin for TMO stock is 11.84%.
Thermo Fisher Scientific Inc. Net Profit Margin History
| DATE | NET PROFIT MARGIN |
|---|---|
| 2025-12-31 | 15.12% |
| 2024-12-31 | 14.77% |
| 2023-12-31 | 13.99% |
| 2022-12-31 | 15.47% |
| 2021-12-31 | 19.70% |
| 2020-12-31 | 19.79% |
| 2019-12-31 | 14.47% |
| 2018-12-31 | 12.06% |
| 2017-12-31 | 10.64% |
| 2016-12-31 | 11.06% |
| 2015-12-31 | 11.64% |
| 2014-12-31 | 11.22% |
| 2013-12-31 | 9.73% |
| 2012-12-31 | 9.42% |
| 2011-12-31 | 11.34% |
| 2010-12-31 | 9.60% |
| 2009-12-31 | 8.41% |
| 2008-12-31 | 9.47% |
| 2007-12-31 | 7.81% |
| 2006-12-31 | 4.46% |
| 2005-12-31 | 8.48% |
| 2004-12-31 | 16.40% |
| 2003-12-31 | 9.54% |
| 2002-12-31 | 14.85% |
| 2001-12-31 | -0.04% |
| 2000-12-31 | -1.58% |
| 1999-12-31 | -7.07% |
| 1998-12-31 | 4.70% |
| 1997-12-31 | 6.73% |
| 1996-12-31 | 6.51% |
Related Metrics
About Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. is a global leader in scientific services, providing a comprehensive range of offerings that include life sciences solutions, advanced analytical instruments, specialized diagnostic products, and an extensive portfolio of laboratory supplies and biopharmaceutical services. The company's reach extends across North America, Europe, Asia-Pacific, and other international markets. Its Life Sciences Solutions division furnishes researchers with essential reagents, state-of-the-art instruments, and consumables vital for biological and medical exploration, the development and manufacturing of therapeutics and vaccines, and the detection of infections and various diseases. This segment encompasses bioscience, genetic science, and bioproduction technologies, serving a broad spectrum of clients in the pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and governmental sectors. The Analytical Instruments segment delivers a variety of precision instruments, consumables, software, and support services to pharmaceutical, biotechnology, academic, governmental, environmental, and industrial research environments, as well as clinical laboratories. The Specialty Diagnostics segment offers an array of diagnostic tools, including liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, alongside calibrators, controls, protein detection assays, and accompanying instruments. This also features the creation and distribution of complete blood test systems to aid in the clinical diagnosis and monitoring of allergies, asthma, and autoimmune diseases. Furthermore, it provides dehydrated and prepared culture media, specimen collection and transport systems, related instrumentation and consumables, human leukocyte antigen (HLA) typing and testing crucial for the organ transplant sector, and other healthcare products. Lastly, the Laboratory Products and Biopharma Services segment supplies laboratory equipment, serves the research and safety markets through its channels, and offers extensive pharmaceutical services, encompassing clinical research support. The company's products and services are distributed through a dedicated direct sales team, customer service professionals, online commerce platforms, and a network of third-party distributors. Its recognized brands include Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD. Thermo Fisher Scientific Inc. was established in 1956 and is headquartered in Waltham, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Marc N. Casper